XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.25.1

CONCENTRATIONS | 6 Months Ended
--- | ---
Dec. 31, 2024
Cash and Cash Equivalents [Abstract] |
CONCENTRATIONS | NOTE 8 – CONCENTRATIONS Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and unsecured trade accounts receivable. The Company maintains cash balances in non-interest-bearing bank deposit accounts at a California commercial bank. The Company’s cash balance at this institution is secured by the Federal Deposit Insurance Corporation up to $250,000. As of December 31, 2024 and June 30, 2024, the cash balance was approximately $883,000 and $643,000, respectively. The Company has not experienced any losses in such accounts. Management believes that the Company is not exposed to any significant credit risk with respect to its cash. Customer Concentrations During the three months ended December 31, 2024, the Company had three major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $12,238,000 or 73% of total revenues. During the six months ended December 31, 2024, the Company had three major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $23,741,000 or 72% of total revenues. During the three months ended December 31, 2023, the Company had three major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $13,666,000 or 75% of total revenues. During the six months ended December 31, 2023, the Company had three major customers that each represented more than 10% of revenues on an individual basis and together represented approximately $26,221,000 or 79% of total revenues. Suppliers/Vendor Concentrations The Company obtains components and supplies included in its products from a group of suppliers. During the three months ended December 31, 2024, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $3,532,000 or 26% of total purchases. During the six months ended December 31, 2024, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $7,518,000 or 28% of total purchases. During the three months ended December 31, 2023, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $3,674,000 or 30% of total purchases. During the six months ended December 31, 2023, the Company had one supplier that accounted for more than 10% of total purchases on an individual basis and represented approximately $6,965,000 or 29% of total purchases.

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration